Marc Schwabish - Jan 28, 2025 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)

Role
Chief Business Officer
Signature
/s/ Daniel Lochner, Attorney-in-Fact
Stock symbol
TECX
Transactions as of
Jan 28, 2025
Transactions value $
$6,426
Form type
4
Date filed
1/29/2025, 04:05 PM
Previous filing
Dec 11, 2024
Next filing
Feb 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECX Common Stock Options Exercise $6.43K +2.7K +135% $2.38 4.7K Jan 28, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECX Employee Stock Option (Right to Buy) Options Exercise -2.7K -3.03% 86.5K Jan 28, 2025 Common Stock 2.7K $2.38 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest as to 25% of the shares on March 15, 2022 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
F2 Received in exchange for a stock option to acquire 170,679 shares of common stock pursuant to that certain merger, as more fully described on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017972/xslF345X05/form4-06242024_080616.xml